NCT04111744

Brief Summary

Patients (pts) with stable coronary artery disease (CAD) requiring coronary artery bypass graft surgery (CABG) may be physically inactive during the waiting period to avoid further risks. Aim of this study is to investigate the feasibility and safety of a preoperative aerobic exercise training in these pts during the waiting period and to analyze its effects on pre-, peri and postoperative outcomes

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
203

participants targeted

Target at P50-P75 for not_applicable coronary-artery-disease

Timeline
Completed

Started Jan 2015

Typical duration for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

March 21, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
9 months until next milestone

First Posted

Study publicly available on registry

October 1, 2019

Completed
Last Updated

October 1, 2019

Status Verified

September 1, 2019

Enrollment Period

3.5 years

First QC Date

March 21, 2018

Last Update Submit

September 30, 2019

Conditions

Keywords

Coronary Artery Bypass Graft SurgeryPhysical ActivityCoronary Artery DiseasePhysical Training

Outcome Measures

Primary Outcomes (2)

  • Cardiopulmonary fitness

    Change of maximal Oxygen consumption

    Baseline, prior surgery on hospital admission day, hospital discharge day ( postoperative day 7-14) , after 3 weeks of cardiac rehabilitation

  • Endothelial function

    Change of Reactive hyperemic index (RHI)

    Baseline, prior surgery on hospital admission day, hospital discharge day (postoperative day 7-14), after 3 weeks of cardiac rehabilitation

Secondary Outcomes (21)

  • Length of hospital stay (LoS)

    Within the acute care period

  • Length of ventilation

    Within the acute care period

  • Functional capacity

    Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation

  • Arterial stiffness

    Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation

  • Quality of life Questionnaire 1

    Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation

  • +16 more secondary outcomes

Study Arms (2)

Training Group

EXPERIMENTAL

Preoperative Exercise Training Optimal medical therapy,

Other: Preoperative Exercise TrainingOther: Optimal medical therapy

Control Group

OTHER

Optimal medical therapy, inactive control group

Other: Optimal medical therapy

Interventions

Patients undergoing CABG and randomized to the Training Group complete six sessions of aerobic endurance training prior CABG surgery

Training Group

Standard medication for stable CAD

Control GroupTraining Group

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • stable Angina
  • indication for elective CABG surgery
  • functional capacity \> 50 watts
  • willingness to participate in the study

You may not qualify if:

  • unstable Angina
  • comorbidities precluding performance of aerobic exercise training (e.g. neurological disorders, orthopedic disorders etc)
  • functional Status NYHA IV
  • relevant ventricular arrhythmias
  • hemodynamic significant heart valve disease
  • myocarditis
  • cardiomyopathies
  • left main coronary artery disease \> 50%
  • peripheral obstructive disease (Fontaine \> IIb)
  • reduced life expectancy \< 12 months
  • CABG surgery during the last six months
  • participation in another trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kerckhoff Klinik

Bad Nauheim, 61231, Germany

Location

Related Publications (1)

  • Steinmetz C, Bjarnason-Wehrens B, Baumgarten H, Walther T, Mengden T, Walther C. Prehabilitation in patients awaiting elective coronary artery bypass graft surgery - effects on functional capacity and quality of life: a randomized controlled trial. Clin Rehabil. 2020 Oct;34(10):1256-1267. doi: 10.1177/0269215520933950. Epub 2020 Jun 16.

MeSH Terms

Conditions

Coronary Artery DiseaseMotor Activity

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesBehavior

Study Officials

  • Claudia Walther, MD

    Kerckhoff Clinic

    PRINCIPAL INVESTIGATOR
  • Heike Baumgarten, MD

    Kerckhoff Clinik

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Patients enrolled to the study were randomised in a Treatment and a control Group
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 21, 2018

First Posted

October 1, 2019

Study Start

January 1, 2015

Primary Completion

June 30, 2018

Study Completion

December 31, 2018

Last Updated

October 1, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will not share

Locations